Delivery Order SPE2DB20D3101-SPE2DB25FRSS2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $5,028.35. This competitively awarded, firm fixed-price delivery order is set to conclude by September 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,743.34 for Valtoco 10 mg nasal sprays, a medication used in emergency seizure management. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.92 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, valued at $2,252.20 under a firm fixed-price contract structure. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal spray, with an ultimate completion date of August 4, 2025. This firm fixed-price contract, issued on August 1, 2025, represents a non-set-aside competitive award with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency has awarded a delivery order totaling $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This contract is not set-aside and was competitively awarded to the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.10 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Valtoco 5 mg nasal spray, a seizure rescue medication. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Valtoco 10 mg nasal spray in a 5-pack unit configuration. This competitively awarded, non-set-aside contract carries a ceiling value of $3,388.86 under firm fixed pricing terms, with ultimate completion scheduled for June 27, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Valtoco 10 mg nasal sprays. The contract is non-competitive with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 29, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSS2Delivery Order
The Defense Logistics Agency awarded a $6,974.88 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Valtoco nasal spray—an acute seizure treatment—exemplifies the company's role in providing specialized medications to support the Defense Health Agency and broader military healthcare programs through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 8/15/25 |